Tangible Shareholders Equity: The value shareholders equity less intangible assets.
NeuroSense Therapeutics Ltd. (NRSN) had Tangible Shareholders Equity of $-2.10M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.84M |
|
$0.05M |
|
$0.05M |
|
$0.90M |
|
$3.00M |
|
-- |
|
-- |
|
$3.00M |
|
$-2.10M |
|
|
Tangible Shareholders Equity |
$-2.10M |
$-2.10M |
|
1.84M |
|
| Cash Flow Statement Financials | |
$-1.99M |
|
$-0.01M |
|
$2.07M |
|
$0.17M |
|
$0.23M |
|
$0.07M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|